Villere ST Denis J & Co. LLC held its stake in Colgate-Palmolive Company (NYSE:CL) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,888 shares of the company’s stock at the end of the first quarter. Villere ST Denis J & Co. LLC’s holdings in Colgate-Palmolive were worth $430,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in CL. Bank of New York Mellon Corp increased its position in shares of Colgate-Palmolive by 0.9% in the first quarter. Bank of New York Mellon Corp now owns 18,821,363 shares of the company’s stock valued at $1,377,537,000 after buying an additional 169,798 shares during the last quarter. Renaissance Technologies LLC increased its position in Colgate-Palmolive by 23.4% in the fourth quarter. Renaissance Technologies LLC now owns 8,453,600 shares of the company’s stock valued at $553,204,000 after buying an additional 1,605,600 shares in the last quarter. Norges Bank acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $455,526,000. First Eagle Investment Management LLC boosted its stake in Colgate-Palmolive by 2.6% in the first quarter. First Eagle Investment Management LLC now owns 4,782,281 shares of the company’s stock worth $350,015,000 after buying an additional 122,983 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in Colgate-Palmolive by 0.4% in the fourth quarter. Franklin Resources Inc. now owns 4,518,918 shares of the company’s stock worth $295,724,000 after buying an additional 17,908 shares in the last quarter. 73.50% of the stock is currently owned by institutional investors and hedge funds.
Shares of Colgate-Palmolive Company (NYSE CL) traded up 1.64% during mid-day trading on Friday, reaching $73.27. 7,173,340 shares of the company’s stock were exchanged. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The company has a 50 day moving average price of $74.80 and a 200 day moving average price of $72.20. The firm has a market cap of $64.72 billion, a P/E ratio of 26.44 and a beta of 0.80. Colgate-Palmolive also saw unusually large options trading activity on Thursday. Traders purchased 11,545 put options on the company. This is an increase of approximately 508% compared to the average volume of 1,900 put options.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 16.31% and a return on equity of 3,725.55%. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the previous year, the firm earned $0.70 earnings per share. The company’s revenue for the quarter was down .5% on a year-over-year basis. Analysts forecast that Colgate-Palmolive Company will post $2.93 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.76%.
A number of research firms have issued reports on CL. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Jefferies Group LLC increased their price objective on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a research note on Thursday, July 6th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Tuesday, July 4th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research note on Friday, June 30th. Finally, Bank of America Corporation raised their target price on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $75.69.
In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $75.67, for a total transaction of $290,043.11. Following the transaction, the insider now owns 53,022 shares in the company, valued at $4,012,174.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard J. Kogan sold 8,000 shares of the business’s stock in a transaction on Monday, May 8th. The shares were sold at an average price of $71.92, for a total transaction of $575,360.00. Following the sale, the director now directly owns 73,065 shares of the company’s stock, valued at $5,254,834.80. The disclosure for this sale can be found here. Insiders sold 29,666 shares of company stock worth $2,144,371 in the last three months. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with our FREE daily email newsletter.